Caron A. Lyman

Experimental Pulmonary Aspergillosis Due to<i>Aspergillus terreus:</i>Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B

Thomas J. Walsh, Vidmantas Petraitis, Rūta Petraitienė et al. · The Journal of Infectious Diseases · 2003 · 255 citations

Life Sciences, Infectious Diseases, Microbiology +17

Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: Synergistic Interaction between an Antifungal Triazole and an Echinocandin

Vidmantas Petraitis, Rūta Petraitienė, Alia A. Sarafandi et al. · The Journal of Infectious Diseases · 2003 · 234 citations

Medicine, Infectious Diseases, Pharmacology +17

Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

Vidmantas Petraitis, Rūta Petraitienė, Andreas H. Groll et al. · Antimicrobial Agents and Chemotherapy · 2002 · 181 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetic and Pharmacodynamic Modeling of Anidulafungin (LY303366): Reappraisal of Its Efficacy in Neutropenic Animal Models of Opportunistic Mycoses Using Optimal Plasma Sampling

Andreas H. Groll, Diana Mickiene, Rūta Petraitienė et al. · Antimicrobial Agents and Chemotherapy · 2001 · 139 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Pathogenesis of <i>Aspergillus fumigatus</i> and the Kinetics of Galactomannan in an In Vitro Model of Early Invasive Pulmonary Aspergillosis: Implications for Antifungal Therapy

William Hope, Michael J. Kruhlak, Caron A. Lyman et al. · The Journal of Infectious Diseases · 2007 · 129 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17